Nabat, New Abu Dhabi Climate Tech Venture, to use AI and Robotics to Restore Mangroves and Boost Climate Resilience
The Advanced Technology Research Council’s VentureOne has unveiled Nabat, a new climate tech venture that will conserve and restore mangroves and other ecosystems across the region using AI and robotics, at the International Mangrove Conservation and Restoration Conference in Abu Dhabi.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241211709642/en/
Nabat, New Abu Dhabi Climate Tech Venture, to use AI and Robotics to Restore Mangroves and Boost Climate Resilience (Photo: AETOSWire)
Nabat showcased their advanced technology, including drones, AI-powered software, and flexible seeding mechanisms, which they will use to conserve and restore thousands of hectares of mangroves across the UAE over the coming seven years. Mangroves store up to five times more carbon than rainforest trees and are a vital component of the UAE’s ecosystem and the world’s fight against climate change.
“Nabat exemplifies how the UAE is leveraging advanced technology to benefit humanity,” said H.E. Faisal Al Bannai, the Secretary General of the Advanced Technology Research Council (ATRC). “By merging innovation with science, we’re driving efforts to restore ecosystems, enhance biodiversity, and strengthen climate resilience to accelerate our country’s journey to net-zero.”
“Technology and nature are often seen to be at odds—but when we combine technology with science-based research to solve critical problems, technology can become one of nature’s most powerful allies,” said Dr. Najwa Aaraj, the CEO of the Technology Innovation Institute, ATRC’s applied research arm and the developer of the technology behind Nabat. “Our system is helping solve several critical challenges related to conservation, one of the most important being data gathering. No two ecosystems are alike—each needs a customized, data-driven approach.”
Nabat’s AI and robotics enable precision mapping, seeding, and monitoring, ensuring conservation and restoration is tailored to each ecosystem’s unique and complex needs. Unlike traditional mangrove planting, which is labor-intensive and can even harm surrounding ecosystems, Nabat’s system touches habitats as lightly as possible.
During the mapping stage, Nabat’s technology provides vast amounts of data about soil as well as the density, elevation, and hydrology of natural habitats. The drone’s seeding mechanism uses optimized trajectory planning and flexible seeding patterns to ensure seeds are planted precisely and only as they are needed. The system also has monitoring capabilities to help ensure planted trees grow safely.
Nabat’s technology works even in hard-to-reach, remote areas, allowing conservation and restoration efforts to scale efficiently while minimizing costs.
Reda Nidhakou, the Acting CEO of VentureOne, Nabat’s parent company, said, “The soul of VentureOne is launching startups that bring groundbreaking technology to the world. The most valuable technology isn’t just innovative, efficient, or profitable—it most importantly makes a measurable positive impact. It’s been a privilege to work hand-in-hand with the team and our broader ecosystem to contribute to the UAE’s sustainability journey in such a fundamental way.”
While the company’s initial focus will be on mangroves in the UAE, they plan to expand to other parts of the region and service additional ecosystems, including desert areas, farmland, forests, and coral reefs.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20241211709642/en/
Contacts
Audrey Fernandes
Audrey.fernandes@edelman.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy27.12.2024 12:00:00 CET | Press Release
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) has approved TEVIMBRA® (tislelizumab-jsgr), in combination with platinum and fluoropyrimidine-based chemotherapy, for the first-line treatment of unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma (G/GEJ) in adults whose tumors express PD-L1 (≥1). “Today’s FDA approval of TEVIMBRA for the treatment of gastric or gastroesophageal junction cancers in PD-L1 positive adult patients marks a significant step forward in our mission to deliver transformative therapies to patients with cancer,” said Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeiGene. “This is the second U.S. approval for TEVIMBRA this year, underscoring its potential to address critical needs in oncology. We remain deeply grateful to the patients, clinicians, and resear
Takeda Announces Approval of HYQVIA ® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia27.12.2024 07:00:00 CET | Press Release
Takeda (TSE:4502/NYSE:TAK) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] in patients with agammaglobulinemia or hypogammaglobulinemia1, disorders characterized by very low or absent levels of antibodies and an increased risk of serious recurring infection caused by primary immunodeficiency (PID) or secondary immunodeficiency (SID)2. The approval marks availability of the first and only facilitated subcutaneous immunoglobulin (fSCIG) therapy as a treatment option for appropriate patients in Japan. HYQVIA is the first plasma-derived therapy for subcutaneous injection in Japan that consists of a combination of one vial of Immunoglobulin 10% and one vial of Recombinant Human Hyaluronidase PH20 (rHuPH20). The administration of rHuPH20 increases the dispersion and absorption of immunoglobulin (IG) in the subcutaneous tissue, allowing larger volumes to be infu
Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 15:00:00 CET | Press Release
Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 100 points. TIME and Statista analyzed 3,000 major companies from 150 countries, focusing exclusively on those with trans
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press Release
The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa
ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press Release
ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors (corner cube prisms) designed to reflect laser beams directly back to their source, regardless of the an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom